Pacific Biosciences of California, Inc. (PACB)

NASDAQ: PACB · IEX Real-Time Price · USD

1.470

+0.090 (6.52%)

At close: Apr 26, 2024, 4:00 PM

1.450

-0.020 (-1.36%)

After-hours: Apr 26, 2024, 6:29 PM EDT

PACB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Cash & Equivalents	180.21	325.39	461.23	82.45	29.93	18.84	16.51	16.77	33.63	36.45	Upgrade
Short-Term Investments	451.51	447.23	583.68	237.2	19.47	83.51	46.37	55.21	48.64	64.9	Upgrade
Cash & Cash Equivalents	631.72	772.62	1,045	319.65	49.4	102.35	62.87	71.98	82.27	101.35	Upgrade
Cash Growth	-18.24%	-26.06%	226.89%	547.08%	-51.74%	62.80%	-12.65%	-12.51%	-18.82%	-9.94%	Upgrade
Receivables	36.62	18.79	24.24	16.84	15.27	8.6	13.43	11.42	5.25	3.41	Upgrade
Inventory	56.68	50.38	24.6	14.23	13.31	17.88	23.07	15.63	10.96	11.34	Upgrade
Other Current Assets	17.04	10.29	7.39	4.87	3.07	2.83	2.25	9.98	12.07	1.67	Upgrade
Total Current Assets	742.05	852.07	1,101	355.59	81.05	131.66	101.62	109.01	110.54	117.76	Upgrade
Property, Plant & Equipment	69.03	81.34	79.12	54.85	62.9	34.07	37.92	14.56	8.55	6.6	Upgrade
Long-Term Investments	2.42	2.92	4.59	3.5	4	4.5	4.5	4.5	4.5	0	Upgrade
Goodwill and Intangibles	919.25	820.22	820.95	0	0	0	0	0	0	0	Upgrade
Other Long-Term Assets	13.27	10.53	1.17	0.04	0.04	0.04	0.05	9.81	7.52	0.03	Upgrade
Total Long-Term Assets	1,004	915.01	905.84	58.39	66.94	38.62	42.47	28.87	20.57	6.63	Upgrade
Total Assets	1,746	1,767	2,007	413.98	147.99	170.28	144.08	137.88	131.11	124.39	Upgrade
Accounts Payable	15.06	12.03	11	3.58	8.37	6.74	9.09	8.36	4.75	5.61	Upgrade
Deferred Revenue	21.87	32.29	36.03	10.29	9.56	7.43	7.39	8.43	20.09	33.77	Upgrade
Current Debt	9.59	8.89	7.71	4.33	19.71	0	0	0	0	0	Upgrade
Other Current Liabilities	48.5	210.13	16.97	20.3	11.52	12.72	12.15	16.99	13.34	-7.89	Upgrade
Total Current Liabilities	95.03	263.34	71.71	38.5	49.15	26.88	28.64	33.77	38.18	31.49	Upgrade
Long-Term Debt	923.85	937.75	946.04	37.67	41.96	14.66	13.64	16.11	14.95	13.99	Upgrade
Other Long-Term Liabilities	25.83	3.09	198.24	2.32	1.95	14.67	15.71	3.34	4.44	23.96	Upgrade
Total Long-Term Liabilities	949.68	940.85	1,144	39.99	43.92	29.33	29.35	19.44	19.39	37.95	Upgrade
Total Liabilities	1,045	1,204	1,216	78.49	93.07	56.21	57.98	53.22	57.57	69.44	Upgrade
Total Debt	933.44	946.64	953.75	42	61.67	14.66	13.64	16.11	14.95	13.99	Upgrade
Debt Growth	-1.39%	-0.75%	2170.88%	-31.90%	320.71%	7.51%	-15.34%	7.75%	6.84%	4.83%	Upgrade
Retained Earnings	-1,839.08	-1,532.34	-1,218.09	-1,036.87	-1,066.24	-982.11	-879.73	-787.54	-713.17	-681.47	Upgrade
Comprehensive Income	0.22	-4.77	-1.09	0.09	0.01	-0.04	-0.03	0.01	-0.01	0.01	Upgrade
Shareholders' Equity	701.3	562.9	790.99	335.49	54.92	114.06	86.1	84.67	73.54	54.95	Upgrade
Net Cash / Debt	-301.72	-174.02	91.15	277.65	-12.27	87.7	49.24	55.87	67.32	87.36	Upgrade
Net Cash / Debt Growth	-	-	-67.17%	-	-	78.11%	-11.88%	-17.01%	-22.93%	-11.92%	Upgrade
Net Cash Per Share	-1.19	-0.77	0.45	1.59	-0.08	0.65	0.47	0.63	0.89	1.24	Upgrade
Working Capital	647.02	588.74	1,029	317.09	31.89	104.78	72.98	75.24	72.36	86.27	Upgrade
Book Value Per Share	2.77	2.51	3.88	2.03	0.36	0.84	0.81	0.95	0.97	0.78	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).